Molina Healthcare director receives 405-share equity grant

ROMNEY RONNA reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

ROMNEY RONNA reported acquisition or exercise transactions in this Form 4 filing.

Molina Healthcare director Ronna Romney received an equity grant through a revocable trust. On April 1, 2026, the Ronna Romney Revocable Trust was awarded 405 shares of Molina Healthcare common stock at a reference price of $135.82 per share under the company’s 2025 Equity Incentive Plan. This quarterly grant represents one quarter of an annual director equity award valued at $220,000, structured as $55,000 in stock each quarter based on the closing market price that day. Following this award, the trust holds a total of 17,632 shares, reflecting routine, compensation-related ownership rather than an open-market purchase or sale.

Insights

Equity compensation analyst

Routine quarterly equity grant to Molina Healthcare director via trust.

This filing shows a standard compensation award, not an open-market trade. Director Ronna Romney, through the Ronna Romney Revocable Trust, received 405 shares under the 2025 Equity Incentive Plan based on the stock’s closing price.

The footnotes explain that directors receive an annual equity award of $220,000, delivered in four quarterly stock grants of $55,000 each. This installment was priced at $135.82 per share, resulting in 405 shares and bringing the trust’s holdings to 17,632 shares.

The transaction is compensation-related, categorized as a grant/award acquisition with no indication of a discretionary buy or sell decision. It mainly signals continued board service and alignment with shareholders rather than a change in investment stance.

Insider Trade Summary

Grant/Award: 405 shares

Grant/Award 1 txn

Insider ROMNEY RONNA

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	405	$135.82	$55K

Holdings After Transaction: Common Stock — 17,632 shares (Indirect, Held by trust)

Footnotes (4)

1. F1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.
2. F2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2026 was $135.82, which resulted in a grant of 405 shares.
3. F3. Represents the closing price of the Issuer's common stock on April 1, 2026.
4. F4. All shares held by Ronna Romney Revocable Trust.

Key Figures

Shares granted: 405 shares Grant pricing reference: $135.82 per share Annual equity award value: $220,000 +2 more

5 metrics

Shares granted 405 shares Quarterly director equity award granted April 1, 2026

Grant pricing reference $135.82 per share Closing price of common stock on April 1, 2026

Annual equity award value $220,000 Total annual equity compensation per director

Quarterly equity award value $55,000 One quarter of annual director equity award each quarter

Post-grant holdings 17,632 shares Total Molina Healthcare shares held by Ronna Romney Revocable Trust after grant

Key Terms

2025 Equity Incentive Plan, annual equity award, Revocable Trust

3 terms

2025 Equity Incentive Plan financial

"Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director."

annual equity award financial

"The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter"

Revocable Trust financial

"All shares held by Ronna Romney Revocable Trust."

A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Molina Healthcare (MOH) director Ronna Romney report in this Form 4?

Ronna Romney reported receiving 405 shares of Molina Healthcare common stock through her revocable trust. The shares were granted as part of her director compensation under the 2025 Equity Incentive Plan, based on the closing stock price on April 1, 2026.

Was the Molina Healthcare (MOH) Form 4 transaction a market buy or sell?

The Form 4 shows a grant, not a market buy or sell. Romney’s revocable trust acquired 405 shares as a stock award under the 2025 Equity Incentive Plan, reflecting routine director compensation rather than an open-market trade or change in investment stance.

How is Molina Healthcare (MOH) compensating directors with equity in this filing?

Directors receive an annual equity award valued at $220,000, split into four quarterly grants of $55,000 each. Each grant is converted into shares using Molina Healthcare’s closing stock price on the grant date, as shown by the 405-share award on April 1, 2026.

What price was used to determine the 405-share grant in Molina Healthcare’s Form 4?

The grant was based on Molina Healthcare’s closing stock price of $135.82 on April 1, 2026. Applying the $55,000 quarterly equity value at that price resulted in a grant of 405 common shares to the Ronna Romney Revocable Trust.

How many Molina Healthcare (MOH) shares does the Ronna Romney Revocable Trust hold after this grant?

After the April 1, 2026 equity grant, the Ronna Romney Revocable Trust holds 17,632 shares of Molina Healthcare common stock. This total reflects indirect ownership reported by director Ronna Romney, primarily from compensation-related stock awards rather than open-market purchases.

Why is the Ronna Romney Revocable Trust mentioned in the Molina Healthcare Form 4?

All reported shares are held by the Ronna Romney Revocable Trust. The Form 4 discloses that Romney’s ownership is indirect through this trust, which receives and holds her director equity awards in Molina Healthcare common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/02/2026 - 04:43 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ROMNEY RONNA

(Last) (First) (Middle)

200 OCEANGATE

SUITE 100

(Street)

LONG BEACH CALIFORNIA 90802

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MOLINA HEALTHCARE, INC. [ MOH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/01/2026		A(1)		405(2)	A	$135.82(3)	17,632	I	Held by trust(4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2026 was $135.82, which resulted in a grant of 405 shares.

3. Represents the closing price of the Issuer's common stock on April 1, 2026.

4. All shares held by Ronna Romney Revocable Trust.

Remarks:

	Jeff D. Barlow, by power of attorney for Ronna Romney.	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)